Skin Diseases In Pregnancy

Abstract

Cilt hastalıklarının çoğu gebe ve gebe olmayan kadınlarda eşit sıklıkta izlenir. Fakat gebeliğin neden olduğu hormonal değişiklikler deride belirgin etkiler yapabilir. Bu nedenle gebeliğe özgü ve semptomatik olan dermatozlar da vardır.Gebelikte görülen cilt hastalıkları üç kategoride izlenir:Hormonal cilt değişiklikleriDaha önceden var olan deri hastalıklarıGebeliğe spesifik hastalıklar Gebelik dermatozları .Gebelikteki hormonal değişiklikler stria gravidarum, hiperpigmentasyon, saç ve tırnak değişiklikleri ve vasküler değişiklikler gibi benign durumları içerir. Daha önceden var olan cilt hastalıkları da gebelikte bazı değişikler gösterir. Çoğu cilt hastalıkları gebeliğin sonlanması ile gerilerken bazı durumlar tedavi gerektirir.

Keywords

• Gebelik,cilt hastalıkları

Gebelikte Cilt Hastalıkları

Abstract

Cilt hastalıklarının çoğu gebe ve gebe olmayan kadınlarda eşit sıklıkta izlenir. Fakat gebeliğin neden olduğu hormonal değişiklikler deride belirgin etkiler yapabilir. Bu nedenle gebeliğe özgü ve semptomatik olan dermatozlar da vardır.Gebelikte görülen cilt hastalıkları üç kategoride izlenir:Hormonal cilt değişiklikleriDaha önceden var olan deri hastalıklarıGebeliğe spesifik hastalıklar Gebelik dermatozları .Gebelikteki hormonal değişiklikler stria gravidarum, hiperpigmentasyon, saç ve tırnak değişiklikleri ve vasküler değişiklikler gibi benign durumları içerir. Daha önceden var olan cilt hastalıkları da gebelikte bazı değişikler gösterir. Çoğu cilt hastalıkları gebeliğin sonlanması ile gerilerken bazı durumlar tedavi gerektirir.

Keywords

• Gebelik,cilt hastalıkları

References

1. Kroumpouzos G, Cohen LM. Dermatoses of pregnancy. J Am Acad Dermatol. 2001;45:1-19.
2. Wong RC, Ellis CN. Physiologic skin changes in pregnancy. J Am Acad Dermatol. 1984;10:929-40.
3. Thomas RG, Liston WA. Clinical associations of striae gravidarum. J Obstet Gynaecol. 2004;24:270-1.
4. Salter SA, Batra RS, Rohrer TE, Kohli N, Kimball AB. Striae and pelvic relaxation: two disorders of connective tissue with a strong association. J Invest Dermatol 2006 ;126:1745-8.
5. Errickson CV, Matus NR. Skin disorders of pregnancy. Am Fam Physician 1994; 49:605-610.
6. Eudy SF, Baker GF. Dermatopathology for the obstetrician. Clin Obstet Gynecol 1990; 33:728-737.
7. Sanchez NP, Pathak MA, Sato S, et al. Melasma: a clinical, lightmicroscopic, ultrastructural, and immuno¯uorescence study. J Am Acad Dermatol 1981; 4:698-710.
8. Winton GB, Lewis CW. Dermatoses of pregnancy. J Am Acad Dermatol 1982; 6:977-998.

9. Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol. 1975;111:40-8.
10. Torok HM, Jones T, Rich P, Smith S, Tschen E. Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma. Cutis. 2005;75:57-62.
11. Headington JT. Telogen effluvium. New concepts and review. Arch Dermatol. 1993;129:356-63.
12. Martin AG, Leal-Khouri S. Physiologic skin changes associated with pregnancy. Int J Dermatol. 1992;31:375-8.
13. Barnhill RL, Wolf Jr JE. Angiogenesis and the skin. J Am Acad Dermatol 1987; 16:1226-1242.
14. Kemmett D, Tidman MJ. The influence of the menstrual cycle and pregnancy on atopic dermatitis. Br J Dermatol. 1991;125:59-61.
15. Ambros-Rudolph CM, Müllegger RR, Vaughan-Jones SA, Kerl H, Black MM: The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol 2006; 54: 395- 404.
16. Ambros-Rudolph CM: Dermatoses of pregnancy. JDDG 2006; 9: 748- 59.
17. Etidy SF. Baker OF. Dennatopathologv tor the obstetrician. Clin Obstet Gynecol 1990; 33: 728-37.
18. Dacus JV. Pruritus in pregnancy. Clin Obstet Gynecol 1990:33:738-745.
19. Pennoyer JM, Grin CM, Driscoll MS: Change in size of melanocytic nevi during pregnancy.J Am Acad Dermatol 1997;36:378-382.
20. Balch CM: Prognostic factors analysis of 17,600 melanoma patients validation of the American Joint Committee on Cancer melanoma staging system. J Clin Onc 2001;19:3622-3634.
21. Nicklas AH, Baker ME: Imaging strategies in the pregnant cancer patient. Semin Oncol 2000;27:623-632.
22. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005;141:1537-41.
23. Tauscher AE, Fleischer AB Jr, Phelps KC, Feldman SR. Psoriasis and pregnancy. J Cutan Med Surg 2002;6:561-70.
24. Rosa FW, Wilk AL, Kelsey FO. Teratogen update: vitamin A congeners. Teratology 1986;33:355-64.
25. Pata O, Tok CE, Yazici G, Pata C, Oz AU, Aban M, et al. Polycythemia vera and pregnancy: a case report with the use of hydroxyurea in the first trimester. Am J Perinatol 2004;21:135-7.
26. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn’s disease and rheumatoid arthritis. Am J Gastroenterol 2004;99:2385-92.
27. Aronson IK, Bond S, Fiedler VC, Vomvouras S, Gruber D, Ruiz C. Pruritic urticarial papules and plaques of pregnancy: clinical and immunopathologic observations in 57 patients [Published correction appears in J Am Acad Dermatol 1999;40:611]. J Am Acad Dermatol. 1998;39:933-9.
28. Kroumpouzos G, Cohen LM. Specific dermatoses of pregnancy: an evidenced-based systematic review. Am J Obstet Gynecol. 2003;188:1083-92.
29. Vaughan Jones SA, Hern S, Nelson-Piercy C, Seed PT, Black MM. A prospective study of 200 women with dermatoses of pregnancy correlating the clinical findings with hormonal and immunopathological profiles. Br J Dermatol 1999; 141: 71-81.
30. Klaus W, Lowell AG, Stephen IK, Barbara AG, Amy SP, David JL. Fitzpatrick’s Dermatology in General Medicine. 7th ed. New York: Mcgraw Hill; 2008: 961-962.
31. Shornick JK, Bangert JL, Freeman RG, Gilliam JN. Herpes gestationis: clinical and histologic features of twenty-eight cases. J Am Acad Dermatol. 1983;8:214-24.
32. Engineer L, Bhol K, Ahmed AR. Pemphigoid gestationis: a review. Am J Obstet Gynecol. 2000;183:483-91.
33. Shimanovich I, Brocker EB, Zillikens D. Pemphigoid gestationis: new insights into pathogenesis lead to novel diagnostic tools. BJOG 2002;109:970-6.
34. Karen JK, Pomeranz MK. Skin Changes and Diseases in Pregnancy. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, eds. Fitzpatrick’s Dermatology in General Medicine. 7th ed. Vol 1. New York: McGraw-Hill, 2008: 955- 62.
35. Mullally B, Hansen W. Intrahepatic cholestasis of pregnancy: review of the literature. Obestet Gynecol Surv. 2002; 57: 47-52.
36. Lammert F, Marschall H-U, Glantz A, Matern S: Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000; 33: 1012- 21.
37. Ropponen A, Sund R, Riikionen S, et al. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population- based study. Hepatology. 2006;43:723-8.
38. Shornick JK. Pregnancy dermatoses. In:. Bolognia JL, Jorizzo JL, Rapini RP, Callen JP, Horn TD, Mancini AJ, eds Dermatology. 2nd ed. Vol 1. New York: Mosby, 2008; 395- 402.
39. Germain AM, Carvajal JA, Glasinovic JC, Kato C S, Williamson C: Intrahepatic Cholestasis of Pregnancy: An Intriguing Pregnancy- Specific Disorder. J Soc Gynecol Investig 2002; 9: 10- 4.
40. Kroumpouzos G: Intrahepatic cholestasis of pregnancy: what’s new ? JEADV 2002; 16: 316- 8.
41. Roncaglia N, Arreghini A, Locatelli A, Bellini P, Andreotti C, Ghidini A.: Obstetric cholestasis: Outcome with active management. Eur J Obstet Gynecol Reprod Biol 2002; 100: 167- 70.
42. Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT, Germain AM: Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994; 170: 890- 5.